Last reviewed · How we verify

NCT05215691: TAPA

Outcomes of Thoracoabdominal Nerve Block Through Perichondrial Approach* on Postoperative Cognitive Functions

Completed Last updated 2 March 2023
What this trial tests

trial testing Group I: TAPA block in Pain, Postoperative in 90 participants. Completed in 10 September 2022.

Timeline
10 March 2022
Primary endpoint
20 August 2022
10 September 2022

Quick facts

Lead sponsorDr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment90
Start date10 March 2022
Primary completion20 August 2022
Estimated completion10 September 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Who can join

Adults 18 to 85, any sex, with Pain, Postoperative or Cognition. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

It was planned to compare the opioid consumption and cognitive functions in the postoperative period of patients who received TAPA block for postoperative analgesia and patients who did not prefer the block and who preferred intravenous patient-controlled analgesia (PCA) with opioids. Both the surgery applied and the drugs used in anesthesia can cause changes in cognitive functions by affecting the inflammatory process. It is thought that if the patients' pain can be relieved sufficiently in the postoperative period with TAPA block, the consumption of opioids used will be less and their cognitive functions will be less affected.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pain, Postoperative

Currently open trials in the same condition.

Other Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05215691.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing